Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:22 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 703,126 9.990% | 703,126 (New Position) | View |
| 2024-07-29 4:45 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | BCLS Fund III Investments LP | 703,080 9.990% | 703,080 (New Position) | View |
| 2024-07-29 4:31 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | Canaan XII L.P. | 1,400,000 9.990% | 1,400,000 (New Position) | View |
| 2024-07-25 4:16 pm Purchase | 13D | CIDARA THERAPEUTICS INC NE CDTX | RA CAPITAL MANAGEMENT L.P. | 703,080 9.990% | 703,080 (New Position) | View |
| 2024-02-14 4:51 pm Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | Nantahala Capital Management LLC | 1,546,745 1.700% | -2,820,719 (-64.58%) | View |
| 2024-02-14 10:18 am Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 9,275,527 9.990% | 2,414,400 (+35.19%) | View |
| 2024-02-14 10:02 am Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | Point72 Asset Management L.P. | 1,250,228 1.400% | -2,617,778 (-67.68%) | View |
| 2023-02-14 4:58 pm Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | Nantahala Capital Management LLC | 4,367,464 6.100% | -902,994 (-17.13%) | View |
| 2023-02-14 4:23 pm Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | Point72 Asset Management L.P. | 3,868,006 5.400% | -450,034 (-10.42%) | View |
| 2022-02-15 1:09 pm Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | LYTTON LAURENCE W | 1,708,328 2.500% | -1,632,072 (-48.86%) | View |
| 2022-02-14 4:48 pm Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | Omega Fund V L.P. | 1,249,999 1.800% | -2,005,249 (-61.60%) | View |
| 2022-02-14 4:41 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | Point72 Asset Management L.P. | 4,318,040 6.500% | 118,040 (+2.81%) | View |
| 2022-02-14 08:30 am Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | Nantahala Capital Management LLC | 5,270,458 7.900% | 5,270,458 (New Position) | View |
| 2022-02-11 4:48 pm Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | BB BIOTECH AG | 0 0.000% | -2,822,495 (Position Closed) | View |
| 2021-12-16 5:16 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 6,861,127 10.300% | 2,399,633 (+53.79%) | View |
| 2021-10-14 5:12 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | Point72 Asset Management L.P. | 4,200,000 6.300% | 4,200,000 (New Position) | View |
| 2021-08-11 7:27 pm Sale | 13D | CIDARA THERAPEUTICS INC NE CDTX | INTERWEST PARTNERS X LP | 903,739 1.900% | -453,074 (-33.39%) | View |
| 2021-03-05 7:26 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | LYTTON LAURENCE W | 3,340,400 7.000% | 613,328 (+22.49%) | View |
| 2021-03-05 4:55 pm Purchase | 13G | CIDARA THERAPEUTICS INC NE CDTX | LYTTON LAURENCE W | 2,727,072 5.700% | 2,727,072 (New Position) | View |
| 2021-02-16 11:39 am Sale | 13G | CIDARA THERAPEUTICS INC NE CDTX | 5AM VENTURES III L.P. | 2,006,511 4.600% | -9,000 (-0.45%) | View |